This raises an essential question: Why does biotechnology continue to thrive despite these financial challenges?

The answer lies in the groundbreaking advancements biotechnology has brought to medicine. The sector is not merely about financial returns—it is about the unparalleled potential to save and improve lives.

A Legacy of Medical Breakthroughs

Consider the treatment of diabetes before the 1970s. Back then, the only available insulin was derived from pigs, which posed various challenges, including supply shortages and potential allergic reactions. Similarly, conditions such as pituitary dwarfism and other genetic disorders had few, if any, effective treatments. The introduction of recombinant DNA technology and synthetic insulin revolutionized these therapies, drastically improving the quality of life for countless individuals.

Beyond insulin, monoclonal antibodies have provided a potent defense against certain cancers, significantly improving survival rates. More recently, gene therapy and DNA manipulation have emerged as pioneering strategies to correct congenital diseases at their root, offering hope to those suffering from previously untreatable genetic conditions.

The Measurable Impact on Life Expectancy

Biotechnology’s contributions to healthcare are reflected in the steady increase in life expectancy over the past century.
These figures highlight biotechnology’s crucial role in extending human life and improving health outcomes. From groundbreaking cancer treatments to the management of chronic illnesses like hemophilia, biotech has played an indispensable role in modern medicine.

Biotechnology has a relevant responsibility in the figures presented on the table. Never before we have been in the condition of recovering people from cancer or giving a good quality life to individuals suffering haemophilia or other terrible diseases. This is why all this money invested is well spent money.